FDA Information
Estradiol was approved by the FDA in 1975 for the treatment of moderate to severe vasomotor symptoms associated with menopause as well as for the prevention of osteoporosis.
Estradiol tablets, the generic equivalent of Bristol Myers Squibb's Estrace®, has been approved for marketing. Barr Pharmaceuticals' estradiol version will be available in 0.5, 1, and 2 mg strengths.
Why is this medication prescribed?
Dosage and using this medicine
What special precautions should I follow?
What should I do if I forget a dose?
What side effects can this medication cause?